Global Financial Private Client’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-61
| Closed | -$38.7K | – | 1281 |
|
|
2025
Q1 | $38.7K | Buy |
61
+2
| +3% | +$1.27K | 0.01% | 365 |
|
|
2024
Q4 | $42K | Sell |
59
-6
| -9% | -$4.27K | 0.02% | 336 |
|
|
2024
Q3 | $68.3K | Buy |
65
+21
| +48% | +$22.1K | 0.03% | 297 |
|
|
2024
Q2 | $46.2K | Hold |
44
| – | – | 0.02% | 306 |
|
|
2024
Q1 | $42.7K | Hold |
44
| – | – | 0.02% | 320 |
|
|
2023
Q4 | $38.6K | Hold |
44
| – | – | 0.02% | 320 |
|
|
2023
Q3 | $36K | Hold |
44
| – | – | 0.02% | 315 |
|
|
2023
Q2 | $31.6K | Hold |
44
| – | – | 0.02% | 331 |
|
|
2023
Q1 | $36.4K | Hold |
44
| – | – | 0.02% | 314 |
|
|
2022
Q4 | $31.7K | Hold |
44
| – | – | 0.02% | 319 |
|
|
2022
Q3 | $32.3K | Hold |
44
| – | – | 0.02% | 309 |
|
|
2022
Q2 | $26.2K | Hold |
44
| – | – | 0.01% | 322 |
|
|
2022
Q1 | $30.6K | Hold |
44
| – | – | 0.01% | 316 |
|
|
2021
Q4 | $27.8K | Hold |
44
| – | – | 0.01% | 314 |
|
|
2021
Q3 | $25.1K | Hold |
44
| – | – | 0.01% | 294 |
|
|
2021
Q2 | $25.3K | Hold |
44
| – | – | 0.01% | 299 |
|
|
2021
Q1 | $20.9K | Hold |
44
| – | – | 0.02% | 274 |
|
|
2020
Q4 | $21.3K | Hold |
44
| – | – | 0.02% | 261 |
|
|
2020
Q3 | $25K | Hold |
44
| – | – | 0.02% | 241 |
|
|
2020
Q2 | $26.8K | Sell |
44
-31
| -41% | -$18.9K | 0.02% | 271 |
|
|
2020
Q1 | $37.2K | Buy |
+75
| New | +$37.2K | 0.04% | 240 |
|